Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.


  • New protein biomarker identifies damaged brain wiring after concussion

  • Fruit flies provide new insight into body's rhythms

  • High-fat diet prompts immune cells to start eating connections between neurons

  • Want to remember new names? Sleep on it

  • Adults aged 50-59 now largest age group in opioid treatment programs

  • Children who take ADHD medicines have trouble sleeping, new study shows

  • Blood from small children 'remembers' prenatal smoking exposure

  • Oxytocin increases social altruism

  • First-of-kind dopamine measurements in human brain reveal insights into how we learn

  • Young women who survive cardiovascular event have long-term risks